[1]
“METHOD DEVELOPMENT AND VALIDATION OF ATAZANAVIR AND RITONAVIR IN THE DOSAGE FORM BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY”, Trop. j. pharm. life sci., vol. 9, no. 6, pp. 13–20, Dec. 2022, doi: 10.61280/tjpls.v9i6.109.